Literature DB >> 27881649

The Many Faces of the Flavivirus NS5 Protein in Antagonism of Type I Interferon Signaling.

Sonja M Best1.   

Abstract

The vector-borne flaviviruses cause severe disease in humans on every inhabited continent on earth. Their transmission by arthropods, particularly mosquitoes, facilitates large emergence events such as witnessed with Zika virus (ZIKV) or West Nile virus in the Americas. Every vector-borne flavivirus examined thus far that causes disease in humans, from dengue virus to ZIKV, antagonizes the host type I interferon (IFN-I) response by preventing JAK-STAT signaling, suggesting that suppression of this pathway is an important determinant of infection. The most direct and potent viral inhibitor of this pathway is the nonstructural protein NS5. However, the mechanisms utilized by NS5 from different flaviviruses are often quite different, sometimes despite close evolutionary relationships between viruses. The varied mechanisms of NS5 as an IFN-I antagonist are also surprising given that the evolution of NS5 is restrained by the requirement to maintain function of two enzymatic activities critical for virus replication, the methyltransferase and RNA-dependent RNA polymerase. This review discusses the different strategies used by flavivirus NS5 to evade the antiviral effects of IFN-I and how this information can be used to better model disease and develop antiviral countermeasures.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  JAK-STAT; NS5; West Nile virus; Zika virus; antagonism; dengue virus; flavivirus; interferons; tick-borne encephalitis virus; yellow fever virus

Mesh:

Substances:

Year:  2017        PMID: 27881649      PMCID: PMC5244349          DOI: 10.1128/JVI.01970-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  108 in total

Review 1.  Regulation of antiviral T cell responses by type I interferons.

Authors:  Josh Crouse; Ulrich Kalinke; Annette Oxenius
Journal:  Nat Rev Immunol       Date:  2015-03-20       Impact factor: 53.106

Review 2.  Dynamic control of type I IFN signalling by an integrated network of negative regulators.

Authors:  Rebecca A Porritt; Paul J Hertzog
Journal:  Trends Immunol       Date:  2015-02-25       Impact factor: 16.687

3.  Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression.

Authors:  Meleri Jones; Andrew Davidson; Linda Hibbert; Petra Gruenwald; Joerg Schlaak; Simon Ball; Graham R Foster; Michael Jacobs
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

4.  Molecular basis for specific viral RNA recognition and 2'-O-ribose methylation by the dengue virus nonstructural protein 5 (NS5).

Authors:  Yongqian Zhao; Tingjin Sherryl Soh; Siew Pheng Lim; Ka Yan Chung; Kunchithapadam Swaminathan; Subhash G Vasudevan; Pei-Yong Shi; Julien Lescar; Dahai Luo
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-17       Impact factor: 11.205

5.  Flavivirus Antagonism of Type I Interferon Signaling Reveals Prolidase as a Regulator of IFNAR1 Surface Expression.

Authors:  Kirk J Lubick; Shelly J Robertson; Kristin L McNally; Brett A Freedman; Angela L Rasmussen; R Travis Taylor; Avram D Walts; Seitaro Tsuruda; Mizuki Sakai; Mariko Ishizuka; Elena F Boer; Erin C Foster; Abhilash I Chiramel; Conrad B Addison; Richard Green; Daniel L Kastner; Michael G Katze; Steven M Holland; Antonella Forlino; Alexandra F Freeman; Manfred Boehm; Kentaro Yoshii; Sonja M Best
Journal:  Cell Host Microbe       Date:  2015-07-08       Impact factor: 21.023

Review 6.  Regulation of type I interferon responses.

Authors:  Lionel B Ivashkiv; Laura T Donlin
Journal:  Nat Rev Immunol       Date:  2014-01       Impact factor: 53.106

Review 7.  Hope and fear for interferon: the receptor-centric outlook on the future of interferon therapy.

Authors:  Serge Y Fuchs
Journal:  J Interferon Cytokine Res       Date:  2013-04       Impact factor: 2.607

8.  Zika Virus Targets Human STAT2 to Inhibit Type I Interferon Signaling.

Authors:  Alesha Grant; Sanket S Ponia; Shashank Tripathi; Vinod Balasubramaniam; Lisa Miorin; Marion Sourisseau; Megan C Schwarz; Mari Paz Sánchez-Seco; Matthew J Evans; Sonja M Best; Adolfo García-Sastre
Journal:  Cell Host Microbe       Date:  2016-05-19       Impact factor: 21.023

Review 9.  Immunity-related genes in Ixodes scapularis--perspectives from genome information.

Authors:  Alexis A Smith; Utpal Pal
Journal:  Front Cell Infect Microbiol       Date:  2014-08-22       Impact factor: 5.293

10.  Characterization of a Novel Murine Model to Study Zika Virus.

Authors:  Shannan L Rossi; Robert B Tesh; Sasha R Azar; Antonio E Muruato; Kathryn A Hanley; Albert J Auguste; Rose M Langsjoen; Slobodan Paessler; Nikos Vasilakis; Scott C Weaver
Journal:  Am J Trop Med Hyg       Date:  2016-03-28       Impact factor: 2.345

View more
  71 in total

1.  West Nile Virus-Inclusive Single-Cell RNA Sequencing Reveals Heterogeneity in the Type I Interferon Response within Single Cells.

Authors:  Justin T O'Neal; Amit A Upadhyay; Amber Wolabaugh; Nirav B Patel; Steven E Bosinger; Mehul S Suthar
Journal:  J Virol       Date:  2019-03-05       Impact factor: 5.103

2.  Robust dengue virus infection in bat cells and limited innate immune responses coupled with positive serology from bats in IndoMalaya and Australasia.

Authors:  Aaron T Irving; Pritisha Rozario; Pui-San Kong; Katarina Luko; Jeffrey J Gorman; Marcus L Hastie; Wan Ni Chia; Shailendra Mani; Benjamin Py-H Lee; Gavin J D Smith; Ian H Mendenhall; H Benjamin Larman; Stephen J Elledge; Lin-Fa Wang
Journal:  Cell Mol Life Sci       Date:  2019-07-27       Impact factor: 9.261

Review 3.  Structure and function of Zika virus NS5 protein: perspectives for drug design.

Authors:  Boxiao Wang; Stephanie Thurmond; Rong Hai; Jikui Song
Journal:  Cell Mol Life Sci       Date:  2018-02-08       Impact factor: 9.261

4.  Zika Virus Production Is Resistant to RNase L Antiviral Activity.

Authors:  Jillian N Whelan; Yize Li; Robert H Silverman; Susan R Weiss
Journal:  J Virol       Date:  2019-07-30       Impact factor: 5.103

5.  Immune Evasion Strategies Used by Zika Virus to Infect the Fetal Eye and Brain.

Authors:  Branden R Nelson; Justin A Roby; William B Dobyns; Lakshmi Rajagopal; Michael Gale; Kristina M Adams Waldorf
Journal:  Viral Immunol       Date:  2019-11-05       Impact factor: 2.257

Review 6.  Zika virus and the nonmicrocephalic fetus: why we should still worry.

Authors:  Christie L Walker; Marie-Térèse E Little; Justin A Roby; Blair Armistead; Michael Gale; Lakshmi Rajagopal; Branden R Nelson; Noah Ehinger; Brittney Mason; Unzila Nayeri; Christine L Curry; Kristina M Adams Waldorf
Journal:  Am J Obstet Gynecol       Date:  2018-08-29       Impact factor: 8.661

7.  Selective Activation of Type II Interferon Signaling by Zika Virus NS5 Protein.

Authors:  Vidyanath Chaudhary; Kit-San Yuen; Jasper Fuk-Woo Chan; Ching-Ping Chan; Pei-Hui Wang; Jian-Piao Cai; Shuo Zhang; Mifang Liang; Kin-Hang Kok; Chi-Ping Chan; Kwok-Yung Yuen; Dong-Yan Jin
Journal:  J Virol       Date:  2017-06-26       Impact factor: 5.103

8.  Zika virus pathogenesis and current therapeutic advances.

Authors:  Caroline Mwaliko; Raphael Nyaruaba; Lu Zhao; Evans Atoni; Samuel Karungu; Matilu Mwau; Dimitri Lavillette; Han Xia; Zhiming Yuan
Journal:  Pathog Glob Health       Date:  2020-11-14       Impact factor: 2.894

9.  NS5 Sumoylation Directs Nuclear Responses That Permit Zika Virus To Persistently Infect Human Brain Microvascular Endothelial Cells.

Authors:  Jonas N Conde; William R Schutt; Megan Mladinich; Sook-Young Sohn; Patrick Hearing; Erich R Mackow
Journal:  J Virol       Date:  2020-09-15       Impact factor: 5.103

Review 10.  Host genetic control of mosquito-borne Flavivirus infections.

Authors:  Caroline Manet; Claude Roth; Ahmed Tawfik; Tineke Cantaert; Anavaj Sakuntabhai; Xavier Montagutelli
Journal:  Mamm Genome       Date:  2018-08-25       Impact factor: 2.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.